Exact Mass: 441.25488040000005
Exact Mass Matches: 441.25488040000005
Found 116 metabolites which its exact mass value is equals to given mass value 441.25488040000005
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lisinopril dihydrate
C21H31N3O5. 2H2O (441.24748800000003)
Therapeutic category: 2144 2179
Leukotriene E3
C23H39NO5S (441.25488040000005)
Leukotriene E3 is an eicosanoid derived from 8,11,14-Eicosatrienoic acid by the 5-Lipoxygenase-Leukotriene Pathway. The eicosanoids are a diverse family of molecules that have powerful effects on cell function. They are best known as intercellular messengers, having autocrine and paracrine effects following their secretion from the cells that synthesize them. The diversity of possible products that can be synthesized from eicosatrienoic acid is due, in part to the variety of enzymes that can act on it. Studies have placed many, but not all, of these enzymes at or inside the nucleus. In some cases, the nuclear import or export of eicosatrienoic acid-processing enzymes is highly regulated. Furthermore, nuclear receptors that are activated by specific eicosanoids are known to exist. Taken together, these findings indicate that the enzymatic conversion of eicosatrienoic acid to specific signaling molecules can occur in the nucleus, that it is regulated, and that the synthesized products may act within the nucleus. Leukotriene E3 is also a by-product of the metabolism of leukotriene C3. Although they are primarily known for their roles in asthma, pain, fever and vascular responses, present evidence indicates that eicosanoids exert relevant effects on immune/inflammatory, as well as structural, cells pertinent to fibrogenesis. (PMID: 7306127, 8142566, 16574479, 15896193)Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. Leukotriene E3 is an eicosanoid derived from 8,11,14-Eicosatrienoic acid by the 5-Lipoxygenase-Leukotriene Pathway. The eicosanoids are a diverse family of molecules that have powerful effects on cell function. They are best known as intercellular messengers, having autocrine and paracrine effects following their secretion from the cells that synthesize them. The diversity of possible products that can be synthesized from eicosatrienoic acid is due, in part to the variety of enzymes that can act on it. Studies have placed many, but not all, of these enzymes at or inside the nucleus. In some cases, the nuclear import or export of eicosatrienoic acid-processing enzymes is highly regulated. Furthermore, nuclear receptors that are activated by specific eicosanoids are known to exist. Taken together, these findings indicate that the enzymatic conversion of eicosatrienoic acid to specific signaling molecules can occur in the nucleus, that it is regulated, and that the synthesized products may act within the nucleus. Leukotriene E3 is also a by-product of the metabolism of leukotriene C3. Although they are primarily known for their roles in asthma, pain, fever and vascular responses, present evidence indicates that eicosanoids exert relevant effects on immune/inflammatory, as well as structural, cells pertinent to fibrogenesis. (PMID: 7306127, 8142566, 16574479, 15896193)
Pentanoic acid, 5-(dipentylamino)-5-oxo-4-((3-quinolinylcarbonyl)amino)-, (R)-
C25H35N3O4 (441.26274300000006)
R-1 Methanandamide phosphate
C23H40NO5P (441.2643960000001)
(13R)-11alpha-acetoxy-2alpha-hydroxy-13-isobutyryloxyhetisane|trichodelphinine A
C26H35NO5 (441.25151000000005)
Ile Asn Pro Val
C20H35N5O6 (441.25872100000004)
Ile Asn Val Pro
C20H35N5O6 (441.25872100000004)
Ile Pro Asn Val
C20H35N5O6 (441.25872100000004)
Ile Pro Val Asn
C20H35N5O6 (441.25872100000004)
Ile Val Asn Pro
C20H35N5O6 (441.25872100000004)
Ile Val Pro Asn
C20H35N5O6 (441.25872100000004)
Lys Pro Pro Thr
C20H35N5O6 (441.25872100000004)
Lys Pro Thr Pro
C20H35N5O6 (441.25872100000004)
Lys Thr Pro Pro
C20H35N5O6 (441.25872100000004)
Leu Asn Pro Val
C20H35N5O6 (441.25872100000004)
Leu Asn Val Pro
C20H35N5O6 (441.25872100000004)
Leu Pro Asn Val
C20H35N5O6 (441.25872100000004)
Leu Pro Val Asn
C20H35N5O6 (441.25872100000004)
Leu Val Asn Pro
C20H35N5O6 (441.25872100000004)
Leu Val Pro Asn
C20H35N5O6 (441.25872100000004)
Asn Ile Pro Val
C20H35N5O6 (441.25872100000004)
Asn Ile Val Pro
C20H35N5O6 (441.25872100000004)
Asn Leu Pro Val
C20H35N5O6 (441.25872100000004)
Asn Leu Val Pro
C20H35N5O6 (441.25872100000004)
Asn Pro Ile Val
C20H35N5O6 (441.25872100000004)
Asn Pro Leu Val
C20H35N5O6 (441.25872100000004)
Asn Pro Val Ile
C20H35N5O6 (441.25872100000004)
Asn Pro Val Leu
C20H35N5O6 (441.25872100000004)
Asn Val Ile Pro
C20H35N5O6 (441.25872100000004)
Asn Val Leu Pro
C20H35N5O6 (441.25872100000004)
Asn Val Pro Ile
C20H35N5O6 (441.25872100000004)
Asn Val Pro Leu
C20H35N5O6 (441.25872100000004)
Pro Ile Asn Val
C20H35N5O6 (441.25872100000004)
Pro Ile Val Asn
C20H35N5O6 (441.25872100000004)
Pro Lys Pro Thr
C20H35N5O6 (441.25872100000004)
Pro Lys Thr Pro
C20H35N5O6 (441.25872100000004)
Pro Leu Asn Val
C20H35N5O6 (441.25872100000004)
Pro Leu Val Asn
C20H35N5O6 (441.25872100000004)
Pro Asn Ile Val
C20H35N5O6 (441.25872100000004)
Pro Asn Leu Val
C20H35N5O6 (441.25872100000004)
Pro Asn Val Ile
C20H35N5O6 (441.25872100000004)
Pro Asn Val Leu
C20H35N5O6 (441.25872100000004)
Pro Pro Lys Thr
C20H35N5O6 (441.25872100000004)
Pro Pro Thr Lys
C20H35N5O6 (441.25872100000004)
Pro Gln Val Val
C20H35N5O6 (441.25872100000004)
Pro Thr Lys Pro
C20H35N5O6 (441.25872100000004)
Pro Thr Pro Lys
C20H35N5O6 (441.25872100000004)
Pro Val Ile Asn
C20H35N5O6 (441.25872100000004)
Pro Val Leu Asn
C20H35N5O6 (441.25872100000004)
Pro Val Asn Ile
C20H35N5O6 (441.25872100000004)
Pro Val Asn Leu
C20H35N5O6 (441.25872100000004)
Pro Val Gln Val
C20H35N5O6 (441.25872100000004)
Pro Val Val Gln
C20H35N5O6 (441.25872100000004)
Gln Pro Val Val
C20H35N5O6 (441.25872100000004)
Gln Val Pro Val
C20H35N5O6 (441.25872100000004)
Gln Val Val Pro
C20H35N5O6 (441.25872100000004)
Thr Lys Pro Pro
C20H35N5O6 (441.25872100000004)
Thr Pro Lys Pro
C20H35N5O6 (441.25872100000004)
Thr Pro Pro Lys
C20H35N5O6 (441.25872100000004)
Val Ile Asn Pro
C20H35N5O6 (441.25872100000004)
Val Ile Pro Asn
C20H35N5O6 (441.25872100000004)
Val Leu Asn Pro
C20H35N5O6 (441.25872100000004)
Val Leu Pro Asn
C20H35N5O6 (441.25872100000004)
Val Asn Ile Pro
C20H35N5O6 (441.25872100000004)
Val Asn Leu Pro
C20H35N5O6 (441.25872100000004)
Val Asn Pro Ile
C20H35N5O6 (441.25872100000004)
Val Asn Pro Leu
C20H35N5O6 (441.25872100000004)
Val Pro Ile Asn
C20H35N5O6 (441.25872100000004)
Val Pro Leu Asn
C20H35N5O6 (441.25872100000004)
Val Pro Asn Ile
C20H35N5O6 (441.25872100000004)
Val Pro Asn Leu
C20H35N5O6 (441.25872100000004)
Val Pro Gln Val
C20H35N5O6 (441.25872100000004)
Val Pro Val Gln
C20H35N5O6 (441.25872100000004)
Val Gln Pro Val
C20H35N5O6 (441.25872100000004)
Val Gln Val Pro
C20H35N5O6 (441.25872100000004)
Val Val Pro Gln
C20H35N5O6 (441.25872100000004)
Val Val Gln Pro
C20H35N5O6 (441.25872100000004)
Leukotriene E3
C23H39NO5S (441.25488040000005)
A leukotriene that is leukotriene E4 in which the non-conjugated double bond has been reduced to a single bond.
5-Methyl-3-(9-oxo-1,8-diaza-tricyclo[10.6.1.013,18]nonadeca-12(19),13,15,17-tetraen-10-ylcarbamoyl)-hexanoic acid
C25H35N3O4 (441.26274300000006)
Lisinopril diydrate
C21H35N3O7 (441.24748800000003)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents
Militarinone E, (rel)-
C26H35NO5 (441.25151000000005)
A natural product found in Isaria farinosa.
Militarinone F, (rel)-
C26H35NO5 (441.25151000000005)
A natural product found in Isaria farinosa.
Lys-Thr-Pro-Pro
C20H35N5O6 (441.25872100000004)
A tetrapeptide composed of L-lysine, L-threonine and two L-proline units joined in sequence by peptide linkages.
(1R,9S,10S,11S)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-N,N-dimethyl-12-(oxan-4-ylmethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C25H35N3O4 (441.26274300000006)
(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C25H35N3O4 (441.26274300000006)
(2R,3R)-2-(hydroxymethyl)-1-(oxane-4-carbonyl)-N-propan-2-yl-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptane-6-carboxamide
C25H35N3O4 (441.26274300000006)
(1S,9R,10R,11R)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-N,N-dimethyl-12-(oxan-4-ylmethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C25H35N3O4 (441.26274300000006)
(2S,3R)-2-(hydroxymethyl)-1-(oxane-4-carbonyl)-N-propan-2-yl-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptane-6-carboxamide
C25H35N3O4 (441.26274300000006)
2-[2,3-Di(trimethylsilyloxy)butoxy]-N-[2-(ethylamino)ethyl]-3-pyridinecarboxamide
C20H39N3O4Si2 (441.24789740000006)
(1r,2r,10s,11r,13s,14r,15s)-14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C26H35NO5 (441.25151000000005)
1,4-dihydroxy-5-(4-hydroxycyclohex-1-en-1-yl)-3-(6,8,10-trimethyldodeca-2,4,6-trienoyl)pyridin-2-one
C26H35NO5 (441.25151000000005)
(1r,2r,4s,5r,8s,10r,12r,13s,14r,16s,17r,19s)-16-(acetyloxy)-11-ethyl-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate
C26H35NO5 (441.25151000000005)
[8-(4,8-dimethylnona-3,7-dien-1-yl)-5,7-dihydroxy-8-methyl-3-oxo-1h,6h,7h,9h-cyclohexa[e]isoindol-2-yl]acetic acid
C26H35NO5 (441.25151000000005)
(1r,2s,7r,8ar)-7-[(3e)-3-(hydroxyimino)prop-1-en-2-yl]-7-methoxy-1,8a-dimethyl-6-oxo-2,8-dihydro-1h-naphthalen-2-yl (2e,4e,6s)-4,6-dimethylocta-2,4-dienoate
C26H35NO5 (441.25151000000005)
1,4-dihydroxy-5-[(1s,4s)-7-oxabicyclo[2.2.1]heptan-1-yl]-3-[(2e,4e,6e,8r,10r)-6,8,10-trimethyldodeca-2,4,6-trienoyl]pyridin-2-one
C26H35NO5 (441.25151000000005)
4,6'-dihydroxy-2',5',5',8'a-tetramethyl-7-(2-oxopropyl)-3,3',4',4'a,6',7',8,8'-octahydro-2'h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-6-one
C26H35NO5 (441.25151000000005)
1,4-dihydroxy-5-{7-oxabicyclo[2.2.1]heptan-1-yl}-3-(6,8,10-trimethyldodeca-2,4,6-trienoyl)pyridin-2-one
C26H35NO5 (441.25151000000005)
2-hydroxy-1-{11-hydroxy-8-isopropyl-18-methoxy-2,5-dimethyl-19-oxa-15-azapentacyclo[11.6.1.0²,¹⁰.0⁵,⁹.0¹⁷,²⁰]icosa-8,13(20),14,16-tetraen-16-yl}ethanone
C26H35NO5 (441.25151000000005)
1-{2-amino-5-oxo-3ah,6h,6ah-furo[3,2-b]furan-3-yl}-3,7,9,11-tetramethylhexadeca-5,7,11,13-tetraene-1,2-dione
C26H35NO5 (441.25151000000005)
7-[3-(hydroxyimino)prop-1-en-2-yl]-7-methoxy-1,8a-dimethyl-6-oxo-2,8-dihydro-1h-naphthalen-2-yl 4,6-dimethylocta-2,4-dienoate
C26H35NO5 (441.25151000000005)
(2r,2'r,4'as,6'r,8'as)-4,6'-dihydroxy-2',5',5',8'a-tetramethyl-7-(2-oxopropyl)-3,3',4',4'a,6',7',8,8'-octahydro-2'h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-6-one
C26H35NO5 (441.25151000000005)
[(7s,8r)-8-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-5,7-dihydroxy-8-methyl-3-oxo-1h,6h,7h,9h-cyclohexa[e]isoindol-2-yl]acetic acid
C26H35NO5 (441.25151000000005)
(1r,2r,10s,11r,13s,14s,15s)-14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C26H35NO5 (441.25151000000005)
(3r,5e,7e,9r,11e,13z)-1-[(3as,6ar)-2-amino-5-oxo-3ah,6h,6ah-furo[3,2-b]furan-3-yl]-3,7,9,11-tetramethylhexadeca-5,7,11,13-tetraene-1,2-dione
C26H35NO5 (441.25151000000005)
2-hydroxy-1-[(1r,2r,5r,10r,11s,18r)-11-hydroxy-8-isopropyl-18-methoxy-2,5-dimethyl-19-oxa-15-azapentacyclo[11.6.1.0²,¹⁰.0⁵,⁹.0¹⁷,²⁰]icosa-8,13(20),14,16-tetraen-16-yl]ethanone
C26H35NO5 (441.25151000000005)
14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C26H35NO5 (441.25151000000005)
2-hydroxy-1-[(1r,2r,5r,10r,11s,18s)-11-hydroxy-8-isopropyl-18-methoxy-2,5-dimethyl-19-oxa-15-azapentacyclo[11.6.1.0²,¹⁰.0⁵,⁹.0¹⁷,²⁰]icosa-8,13(20),14,16-tetraen-16-yl]ethanone
C26H35NO5 (441.25151000000005)